Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.09.02.673671

Integrative reverse vaccinology approach for identification of a vaccine antigen candidate with immunoprotective and anti-fibrotic potential against Schistosoma japonicum-associated liver fibrosis

Yang, Q. X.·Wang, J.·Ming, Y. Z.·Zhang, Y.·Wong, L. P.·Lee, H. Y.
View original source ↗Export metadata ↓

Abstract

Schistosoma japonicum-associated liver fibrosis (SSLF) is a major cause of morbidity in Schistosomiasis, yet no licensed vaccines or specific therapies exist to prevent or treat this complication. Current vaccine development has focused mainly on infection prevention, with limited attention to pathology-driven outcomes such as fibrosis. To address this gap, we developed an in-silico pipeline integrating host single-cell transcriptomic analysis, parasite antigen screening, and structure-based modeling. Single-cell RNA-seq of liver tissues from SSLF and controls identified three fibrosis-related hub proteins: FYN, BCL2, and AKT3. In parallel, parasite antigens curated from public databases were evaluated for immunogenicity and safety using reverse vaccinology principles. Among these, DRE2_SCHJA, an Anamorsin homolog involved in Fe-S cluster assembly, was prioritized as the top candidate. Docking analysis predicted the strongest interaction between DRE2_SCHJA and FYN ({Delta}G = -14.9 kcal/mol), linking the antigen to a central regulator of fibrosis. Unlike Saracatinib, which inhibits FYN at the ATP-binding pocket, DRE2_SCHJA bound to the SH2 domain through both canonical and non-canonical contacts, indicating a different regulatory mechanism. Taken together, these findings suggest DRE2_SCHJA as a potential vaccine candidate with both protective and anti-fibrotic potential against SSLF. While experimental validation is required, this study supports the early identification of SSLF vaccine candidates in a rapid and cost-effective manner and provides a framework applicable to other neglected tropical diseases. Athor summarySchistosoma japonicum (S. japonicum) is a parasitic disease that remains a major health problem in parts of Asia, especially in China. One of its most harmful consequences is liver fibrosis, which causes long-term illness and reduces quality of life. Currently, there are no drugs or vaccines that specifically prevent or treat this condition. In this study, we used a fast and low-cost computer-based method to search for vaccine targets against liver fibrosis caused by S. japonicum. We identified a parasite protein that could serve as a vaccine target, with the potential to prevent fibrosis from developing and to slow its progression. If future studies confirm its role, such a vaccine could greatly improve the long-term health of people living with schistosomiasis and inspire new strategies for vaccine development in other neglected tropical diseases.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yang, Q. X., Wang, J., Ming, Y. Z., Zhang, Y., Wong, L. P., Lee, H. Y.. 2025-09-06. Integrative reverse vaccinology approach for identification of a vaccine antigen candidate with immunoprotective and anti-fibrotic potential against Schistosoma japonicum-associated liver fibrosis. https://doi.org/10.1101/2025.09.02.673671

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗
bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗